LCM
Laurion Capital Management’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
+3,186
| New | +$249K | ﹤0.01% | 188 |
|
|
2024
Q3 | – | Sell |
-8,753
| Closed | -$809K | – | 295 |
|
|
2024
Q2 | $809K | Buy |
+8,753
| New | +$809K | 0.01% | 199 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 241 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 306 |
|
|
2022
Q2 | – | Sell |
-4,270
| Closed | -$503K | – | 422 |
|
|
2022
Q1 | $503K | Buy |
+4,270
| New | +$503K | 0.01% | 189 |
|
|
2021
Q2 | – | Sell |
-50,000
| Closed | -$4.18M | – | 546 |
|
|
2021
Q1 | $4.18M | Sell |
50,000
-323,622
| -87% | -$27.1M | 0.02% | 176 |
|
|
2020
Q4 | $34.1M | Buy |
+373,622
| New | +$34.1M | 0.26% | 23 |
|
|
2020
Q1 | – | Sell |
-34,342
| Closed | -$8.01M | – | 542 |
|
|
2019
Q4 | $8.01M | Buy |
+34,342
| New | +$8.01M | 0.06% | 40 |
|
|
2019
Q3 | – | Sell |
-9,827
| Closed | -$1.82M | – | 665 |
|
|
2019
Q2 | $1.82M | Buy |
+9,827
| New | +$1.82M | 0.02% | 163 |
|
|
2019
Q1 | – | Sell |
-39,349
| Closed | -$6.03M | – | 656 |
|
|
2018
Q4 | $6.03M | Buy |
39,349
+35,511
| +925% | +$5.44M | 0.11% | 83 |
|
|
2018
Q3 | $668K | Buy |
+3,838
| New | +$668K | 0.01% | 400 |
|
|
2016
Q4 | – | Sell |
-3,000
| Closed | -$362K | – | 711 |
|
|
2016
Q3 | $362K | Sell |
3,000
-500
| -14% | -$60.3K | ﹤0.01% | 331 |
|
|
2016
Q2 | $349K | Sell |
3,500
-5,700
| -62% | -$568K | 0.01% | 333 |
|
|
2016
Q1 | $812K | Buy |
+9,200
| New | +$812K | 0.01% | 205 |
|